English   español  

Browsing by Author Perez, Daniel I.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 12 of 12
RightsPreviewIssue DateTitleAuthor(s)Type
openAccessJEIMC_Sciú_2018.pdf.jpg1-Jan-2019Computer-aided molecular design of pyrazolotriazines targeting glycogen synthase kinase 3Sciú, María Lourdes; Sebastián-Pérez, Víctor; Martínez-González, Loreto ; Benitez, Rocio; Perez, Daniel I.; Pérez, Concepción; Campillo, Nuria E.  ; Martínez, Ana; Moyano, Elizabeth Lauraartículo
closedAccessaccesoRestringido.pdf.jpg2010Estrategias terapéuticas en investigación preclínica para la esclerosis múltipleGil, Carmen  ; Perez, Daniel I.; Ceballos, P.; Martínez, Ana  capítulo de libro
closedAccessaccesoRestringido.pdf.jpg2013Evaluation of the effect of compound aqueous solubility in cytochrome P450 inhibition assaysPérez, José; Díaz, Caridad; Salado, Irene G. ; Perez, Daniel I.; Peláez, Fernando; Genilloud, Olga; Vicente, Franciscaartículo
closedAccessaccesoRestringido.pdf.jpg2011Exploring the binding sites of glycogen synthase kinase 3. identification and characterization of allosteric modulation cavitiesPalomo, Valle  ; Soteras, Ignacio ; Perez, Daniel I.; Pérez, Concepción; Gil, Carmen  ; Campillo, Nuria E.  ; Martínez, Ana  artículo
openAccessIJAD2011-280502.pdf.jpg2011Glycogen synthase kinase 3 inhibitors in the next horizon for Alzheimer's disease treatmentMartínez, Ana  ; Gil, Carmen  ; Perez, Daniel I.artículo
closedAccessaccesoRestringido.pdf.jpg2013Lessons learnt from glycogen synthase kinase 3 inhibitors development for Alzheimer's diseaseMartínez, Ana  ; Perez, Daniel I.; Gil, Carmen  artículo
closedAccessaccesoRestringido.pdf.jpg2008PDE7 inhibitors as new drugs for neurological and inflammatory disordersGil, Carmen  ; Campillo, Nuria E.  ; Perez, Daniel I.; Martínez, Ana  artículo
closedAccessaccesoRestringido.pdf.jpg2013Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's diseasePerez-Gonzalez, Rocío; Pascual, Consuelo; Antequera, Desiree; Bolós, Marta; Redondo, Miriam ; Perez, Daniel I.; Pérez-Grijalba, Virginia; Krzyzanowska, Agnieszka; Sarasa, Manuel; Gil, Carmen  ; Ferrer, Isidro; Martínez, Ana  ; Carro, Evaartículo
closedAccessaccesoRestringido.pdf.jpg2014Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosisSalado, Irene G. ; Redondo, Miriam ; Bello, Murilo L.; Pérez, Concepción; Liachko, Nicole F.; Kraemer, Brian C.; Miguel, Laetitia; Lecourtois, Magalie; Gil, Carmen  ; Martínez, Ana  ; Perez, Daniel I.artículo
closedAccessaccesoRestringido.pdf.jpg2011Protein kinases CK1 and CK2 as new targets for neurodegenerative diseasesPerez, Daniel I.; Gil, Carmen  ; Martínez, Ana  artículo
closedAccessaccesoRestringido.pdf.jpg2011Switching reversibility to irreversibility in glycogen synthase kinase 3 inhibitors: Clues for specific design of new compoundsPerez, Daniel I.; Palomo, Valle  ; Pérez, Concepción; Gil, Carmen  ; Dans, Pablo D.; Luque Garriga, Francisco Javier; Conde, Santiago ; Martínez, Ana  artículo
closedAccessaccesoRestringido.pdf.jpg2011The potential role of glycogen synthase kinase 3 inhibitors as Amyotrophic lateral sclerosis pharmacological therapyPalomo, Valle  ; Perez, Daniel I.; Gil, Carmen  ; Martínez, Ana  artículo